The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials

INTRODUCTION: mTOR and its downstream effectors the 4E-binding protein 1 (4EBP1) and the p70 ribosomal S6 kinases (S6K1 and S6K2) are frequently upregulated in breast cancer, and assumed to be driving forces in tumourigenesis, in close connection with oestrogen receptor (ER) networks. Here, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson, Elin, Pérez-Tenorio, Gizeh, Amin, Risul, Bostner, Josefine, Skoog, Lambert, Fornander, Tommy, Sgroi, Dennis C, Nordenskjöld, Bo, Hallbeck, Anna-Lotta, Stål, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978839/
https://www.ncbi.nlm.nih.gov/pubmed/24131622
http://dx.doi.org/10.1186/bcr3557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978839/
https://www.ncbi.nlm.nih.gov/pubmed/24131622
http://dx.doi.org/10.1186/bcr3557

Ejemplares similares